nach oben

Erschienen in:

19.07.2019 | Original Contribution

Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial

verfasst von: André Moreira-Rosário, Cláudia Marques, Helder Pinheiro, Sónia Norberto, Diana Sintra, José António Teixeira, Conceição Calhau, Luís Filipe Azevedo

Erschienen in: European Journal of Nutrition | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Wheat bran fibre has a beneficial effect on gastrointestinal function, but evidence for wheat germ is scarce. Accordingly, we evaluated the effects of daily intake of wheat germ on gastrointestinal discomfort and gut microbiota by adding wheat germ to refined (white) wheat bread, the most consumed bread type. We hypothesised that an improvement in the composition of refined bread could beneficially affect intestinal health without compromising consumers’ acceptance.

Methods

Fifty-five healthy adults were recruited for a randomised, double-blind, crossover, controlled trial comprising two 4-week intervention periods separated by a 5-week washout stage. During the first 4-week period, one group consumed wheat bread enriched with 6 g of wheat germ and the control group consumed non-enriched wheat bread.

Results

Wheat germ-enriched bread was well-appreciated and the number of participants that demonstrated minimal gastrointestinal improvements after wheat-germ intake was higher than in the control arm. Importantly, intake of wheat germ-enriched bread decreased the perceived gastrointestinal discomfort-related quality of life (subscale worries and concerns) over refined white bread. The improvements in the gastrointestinal function were accompanied by favourable changes in gut microbiota, increasing the number of Bacteroides spp. and Bifidobacterium spp.

Conclusions

Adding wheat germ to industrially made white bread without altering sensory properties may promote a healthy gut bacterial microbiota and the gastrointestinal health.

Nur mit Berechtigung zugänglich

Wei R, Ross AB, Su M, Wang J, Guiraud SP, Draper CF, Beaumont M, Jia W, Martin FP (2018) Metabotypes related to meat and vegetable intake reflect microbial, lipid and amino acid metabolism in healthy people. Mol Nutr Food Res 62(21):e1800583. https://doi.org/10.1002/mnfr.201800583 CrossRefPubMed

Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339. https://doi.org/10.1136/gutjnl-2015-309990 CrossRefPubMed

Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369–2379. https://doi.org/10.1056/NEJMra1600266 CrossRefPubMed

Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489(7415):220–230. https://doi.org/10.1038/nature11550 CrossRefPubMedPubMedCentral

Simrén M (2018) Manipulating the gut microbiome as a treatment strategy for functional gastrointestinal disorders. Gastroenterology 155(4):960–962. https://doi.org/10.1053/j.gastro.2018.09.008 CrossRefPubMed

Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG, Rome Foundation C (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62(1):159–176. https://doi.org/10.1136/gutjnl-2012-302167 CrossRefPubMed

De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107(33):14691–14696. https://doi.org/10.1073/pnas.1005963107 CrossRefPubMedPubMedCentral

Holscher HD (2017) Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8(2):172–184. https://doi.org/10.1080/19490976.2017.1290756 CrossRefPubMedPubMedCentral

Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75 CrossRefPubMed

10.

Healey GR, Murphy R, Brough L, Butts CA, Coad J (2017) Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev 75(12):1059–1080. https://doi.org/10.1093/nutrit/nux062 CrossRefPubMed

11.

Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E, Segal E (2017) Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metab 25(6):1243–1253e1245. https://doi.org/10.1016/j.cmet.2017.05.002 CrossRefPubMed

12.

Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalova L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E (2015) Personalized nutrition by prediction of glycemic responses. Cell 163(5):1079–1094. https://doi.org/10.1016/j.cell.2015.11.001 CrossRefPubMed

13.

de Roos B, Brennan L (2017) Personalised interventions—a precision approach for the next generation of dietary intervention studies. Nutrients. https://doi.org/10.3390/nu9080847 CrossRefPubMedPubMedCentral

14.

Fardet A (2010) New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev 23(1):65–134. https://doi.org/10.1017/S0954422410000041 CrossRefPubMed

15.

EFSA (2010) European Food Safety Authority. Scientific Opinion on the substantiation of health claims related to wheat bran fibre and increase in faecal bulk (ID 3066), reduction in intestinal transit time (ID 828, 839, 3067, 4699) and contribution to the maintenance or achievement of a normal body weight (ID 829) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 8(10):1817. http://www.efsa.europa.eu/en/efsajournal/pub/1817. Accessed 13 Jan 2016

16.

Muller-Lissner SA (1988) Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J (Clin Res Ed) 296(6622):615–617CrossRef

17.

Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, O’Dea K, Macrae FA (2004) Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr 79(6):1020–1028. https://doi.org/10.1093/ajcn/79.6.1020 CrossRefPubMed

18.

Rees G, Davies J, Thompson R, Parker M, Liepins P (2005) Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Promot Health 125(1):30–34CrossRefPubMed

19.

Jenkins DJ, Peterson RD, Thorne MJ, Ferguson PW (1987) Wheat fiber and laxation: dose response and equilibration time. Am J Gastroenterol 82(12):1259–1263PubMed

20.

Healey G, Murphy R, Butts C, Brough L, Whelan K, Coad J (2018) Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br J Nutr 119(2):176–189. https://doi.org/10.1017/S0007114517003440 CrossRefPubMed

21.

Lim CC, Ferguson LR, Tannock GW (2005) Dietary fibres as “prebiotics”: implications for colorectal cancer. Mol Nutr Food Res 49(6):609–619. https://doi.org/10.1002/mnfr.200500015 CrossRefPubMed

22.

Le Bourgot C, Apper E, Blat S, Respondek F (2018) Fructo-oligosaccharides and glucose homeostasis: a systematic review and meta-analysis in animal models. Nutr Metab (Lond) 15:9. https://doi.org/10.1186/s12986-018-0245-3 CrossRef

23.

Poeker SA, Geirnaert A, Berchtold L, Greppi A, Krych L, Steinert RE, de Wouters T, Lacroix C (2018) Understanding the prebiotic potential of different dietary fibers using an in vitro continuous adult fermentation model (PolyFermS). Sci Rep 8(1):4318. https://doi.org/10.1038/s41598-018-22438-y CrossRefPubMedPubMedCentral

24.

Arrigonia E, Jorger F, Kolloffel B, Rouleta I, Herenspergerb M, Meileb L, Amadò R (2002) In vitro fermentability of a commercial wheat germ preparation and its impact on the growth of bifidobacteria. Food Res Int 35(5):475–481. https://doi.org/10.1016/S0963-9969(01)00146-6 CrossRef

25.

Matteuzzi D, Swennen E, Rossi M, Hartman T, Lebet V (2004) Prebiotic effects of a wheat germ preparation in human healthy subjects. Food Microbiol 21:119–124. https://doi.org/10.1016/S0740-0020(03)00009-1 CrossRef

26.

Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, Harnedy N, O’Connor K, O’Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O’Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488(7410):178–184. https://doi.org/10.1038/nature11319 CrossRefPubMed

27.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130(5):1480–1491. https://doi.org/10.1053/j.gastro.2005.11.061 CrossRefPubMed

28.

Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH (2008) Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol 103(5):1241–1248. https://doi.org/10.1111/j.1572-0241.2007.01755.x CrossRefPubMed

29.

Moreira-Rosario A, Pinheiro H, Calhau C, Azevedo LF (2016) Can wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects. BMJ Open 6(11):e013098. https://doi.org/10.1136/bmjopen-2016-013098 CrossRefPubMedPubMedCentral

30.

Moreira-Rosario A, Pinheiro H, Marques C, Teixeira JA, Calhau C, Azevedo LF (2019) Does intake of bread supplemented with wheat germ have a preventive role on cardiovascular disease risk markers in healthy volunteers? A randomised, controlled, crossover trial. BMJ Open 9(1):e023662. https://doi.org/10.1136/bmjopen-2018-023662 CrossRefPubMedPubMedCentral

31.

Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr (1999) Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 34(9):870–877CrossRefPubMed

32.

Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE (1999) Psychosocial aspects of the functional gastrointestinal disorders. Gut 45(Suppl 2):II25–II30PubMedPubMedCentral

33.

Pais-Ribeiro J, Marques T (2009) A avaliação do stresse: a propósito de um estudo de adaptação da escala de percepção de stresse. Psicologia Saúde Doenças 10:237–248

34.

Dubois D, Gilet H, Viala-Danten M, Tack J (2010) Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation. Neurogastroenterol Motil 22(2):e54–e63. https://doi.org/10.1111/j.1365-2982.2009.01408.x CrossRefPubMed

35.

Pocock SJ (1983) Clinical trials: a practical approach. Wiley, Chichester

36.

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57:289–300

37.

Kleerebezem M, Vaughan EE (2009) Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 63:269–290. https://doi.org/10.1146/annurev.micro.091208.073341 CrossRefPubMed

38.

O’Neill I, Schofield Z, Hall LJ (2017) Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerg Top Life Sci 1(4):333–349. https://doi.org/10.1042/ETLS20170058 CrossRefPubMedCentralPubMed

39.

Zhou Y, Zhi F (2016) Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: a meta-analysis. Biomed Res Int 2016:5828959. https://doi.org/10.1155/2016/5828959 CrossRefPubMedPubMedCentral

40.

Romani-Perez M, Agusti A, Sanz Y (2017) Innovation in microbiome-based strategies for promoting metabolic health. Curr Opin Clin Nutr Metab Care 20(6):484–491. https://doi.org/10.1097/MCO.0000000000000419 CrossRefPubMed

41.

Schwalm ND 3rd, Groisman EA (2017) Navigating the gut buffet: control of polysaccharide utilization in Bacteroides spp. Trends Microbiol 25(12):1005–1015. https://doi.org/10.1016/j.tim.2017.06.009 CrossRefPubMed

42.

Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V, Fong SB, Bonnaure-Mallet M, Jolivet-Gougeon A (2017) Roseburia spp.: a marker of health? Future Microbiol 12:157–170. https://doi.org/10.2217/fmb-2016-0130 CrossRefPubMed

43.

Fais T, Delmas J, Cougnoux A, Dalmasso G, Bonnet R (2016) Targeting colorectal cancer-associated bacteria: a new area of research for personalized treatments. Gut Microbes 7(4):329–333. https://doi.org/10.1080/19490976.2016.1155020 CrossRefPubMedPubMedCentral

44.

Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489(7415):242–249. https://doi.org/10.1038/nature11552 CrossRefPubMed

45.

Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, Consortium MI-O, Dumas ME, Rizkalla SW, Dore J, Cani PD, Clement K (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65(3):426–436. https://doi.org/10.1136/gutjnl-2014-308778 CrossRefPubMed

46.

Burton PM, Monro JA, Alvarez L, Gallagher E (2011) Glycemic impact and health: new horizons in white bread formulations. Crit Rev Food Sci Nutr 51(10):965–982. https://doi.org/10.1080/10408398.2010.491584 CrossRefPubMed

47.

Whitton C, Nicholson SK, Roberts C, Prynne CJ, Pot GK, Olson A, Fitt E, Cole D, Teucher B, Bates B, Henderson H, Pigott S, Deverill C, Swan G, Stephen AM (2011) National Diet and Nutrition Survey: UK food consumption and nutrient intakes from the first year of the rolling programme and comparisons with previous surveys. Br J Nutr 106(12):1899–1914. https://doi.org/10.1017/S0007114511002340 CrossRefPubMedPubMedCentral

48.

Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R (2014) Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil 26(1):21–27. https://doi.org/10.1111/nmo.12217 CrossRefPubMed

49.

Tack J, Camilleri M, Dubois D, Vandeplassche L, Joseph A, Kerstens R (2015) Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Neurogastroenterol Motil 27(3):397–405. https://doi.org/10.1111/nmo.12505 CrossRefPubMed

Titel: Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial
verfasst von: André Moreira-Rosário
Cláudia Marques
Helder Pinheiro
Sónia Norberto
Diana Sintra
José António Teixeira
Conceição Calhau
Luís Filipe Azevedo
Publikationsdatum: 19.07.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 5/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-02045-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study

Does l-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials

Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?

Effects of spirulina and wakame consumption on intestinal cholesterol absorption and serum lipid concentrations in non-hypercholesterolemic adult men and women

Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study

Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin